Basel Medical Group Ltd Ordinary Shares

BMGL | NASDAQ

$5.11

+$0.07 (+1.39%)

At close: Nov 2, 2026, 4:00 PM ET

$5.00

-$0.04 (-0.79%)

Pre-market: Nov 2, 2026, 9:25 AM ET

TTM Period Ending	Q2 2025 Dec 31, 2025	Q4 2024 Jun 30, 2025	Q2 2024 Dec 31, 2024	Q4 2023 Jun 30, 2024	Q2 2023 Dec 31, 2023	Q4 2022 Jun 30, 2023
Cash & Equivalents	1.34M	2.98M	7.45M	1.95M	943.58K	1.22M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	99.98	49	n/a	n/a	n/a	n/a
Other Long-Term Assets	32.14K	n/a	n/a	n/a	n/a	n/a
Receivables	12.25M	2.49M	1.42M	12.44M	13.83M	13.33M
Inventory	332.76K	376.29K	99.31K	72.03K	110.23K	94.6K
Other Current Assets	n/a	31.8K	1.89M	1.59M	1.31M	n/a
Total Current Assets	14.14M	13.12M	14.46M	16.17M	16.33M	14.77M
Property-Plant & Equipment	5.9M	3.45M	399.8K	57.97K	321.58K	578.78K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	5.98M	3.74M	476.81K	134.98K	349.15K	606.35K
Total Assets	20.12M	16.85M	14.93M	16.31M	16.68M	15.38M
Account Payables	1.47M	2.1M	1.18M	829.32K	969.27K	1.46M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	3.83M	61.37K	4M	2.68M	2.91M	3.22M
Other Current Liabilities	2.22M	15K	229.8K	458.32K	816.6K	490.73K
Total Current Liabilities	7.52M	10.69M	7.67M	7.16M	7.36M	6.47M
Long-Term Debt	2.01M	n/a	n/a	1.58M	2.5M	3.4M
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	6.08M	1.3M	n/a	1.58M	2.5M	3.42M
Total Liabilities	13.6M	11.99M	7.67M	8.75M	9.86M	9.89M
Total Debt	9.87M	3.42M	4.37M	4.29M	5.73M	7.21M
Book Value	6.52M	4.86M	n/a	n/a	n/a	n/a
Book Value Per Share	4.17	0.26	n/a	n/a	n/a	n/a
Common Stock	34.2M	34.21M	24.46M	24.46M	24.46M	8
Retained Earnings	-28.13M	-4.4M	7.27M	7.56M	6.82M	5.49M
Comprehensive Income	211.5K	-24.95M	-24.47M	-24.46M	-24.46M	n/a
Shareholders Equity	6.28M	4.86M	7.26M	7.56M	6.82M	5.49M
Total Investments	99.98	49	n/a	n/a	n/a	n/a